The world of finance, connected.EN / Global
MY
CompanyCompany profileReviewed 2026-10-23

MYRIAD GENETICS INC

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy (precision medicine), assess a patient's risk of disease progression and disease recurrence (precision medicine), and measure disease activity.

Sources and references ↗
COMPANY PROFILE / 11 SOURCE-LINKED FIELDS

Basic company information

Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.

Business sectors
pharmaceutical industry [1]
Company / filing name
MYRIAD GENETICS INC [2]
Headquarters location
Salt Lake City [1]
Founded
1992 [1]
Legal form
public company [1]
Founders
Mark Skolnick [1]
Official website
myriad.com ↗ [1]
ISIN (reported securities)
US62855J1043 [1]
CIK
899923 [2]
Country in background record
United States [1]
Symbols / exchanges
MYGN (Nasdaq) [2]

Company positioning and business

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy (precision medicine), assess a patient's risk of disease progression and disease recurrence (precision medicine), and measure disease activity. [3]

Background text: Wikipedia contributors, Myriad Genetics. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.

Financial year, securities and disclosures

Listed securities: MYGN (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [2]

History and key events

  1. Founding / inception date recorded in Wikidata. [1]

Financial results and regulatory disclosures

No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]

Related entities and concepts

Frequently asked questions

When was MYRIAD GENETICS INC founded?

Founded: 1992. The linked source provides the background record. [1]

Where is the headquarters of MYRIAD GENETICS INC?

Headquarters location: Salt Lake City. The linked source provides the background record. [1]

Which business sectors are recorded for MYRIAD GENETICS INC?

Business sectors: pharmaceutical industry. The linked source provides the background record. [1]

Sources and review dates

  1. Wikidata — company background record (CC0) ↗
  2. Company identity and profile data ↗
  3. Wikipedia contributors — Myriad Genetics (CC BY-SA 4.0) ↗

Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.

Content preparation: source-based compilation with AI assistance. See methods and attribution. Named sources identify the underlying records; no individual expert review is claimed.